Report Detail

Request for Sample of this report

Pharma & Healthcare Global Cancer Immunotherapies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3624850
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cancer Immunotherapies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body's immune system to attack tumours.
The Global Info Research report includes an overview of the development of the Cancer Immunotherapies industry chain, the market status of Breast Cancer (Monoclonal Antibodies (MABs), Cancer Vaccines), Leukemia (Monoclonal Antibodies (MABs), Cancer Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Immunotherapies.
Regionally, the report analyzes the Cancer Immunotherapies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Immunotherapies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Immunotherapies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Immunotherapies industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies (MABs), Cancer Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Immunotherapies market.
Regional Analysis: The report involves examining the Cancer Immunotherapies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Immunotherapies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Immunotherapies:
Company Analysis: Report covers individual Cancer Immunotherapies manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Immunotherapies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Leukemia).
Technology Analysis: Report covers specific technologies relevant to Cancer Immunotherapies. It assesses the current state, advancements, and potential future developments in Cancer Immunotherapies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Immunotherapies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Immunotherapies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Market segment by Application
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Major players covered
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Immunotherapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Immunotherapies, with price, sales, revenue and global market share of Cancer Immunotherapies from 2019 to 2024.
Chapter 3, the Cancer Immunotherapies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Immunotherapies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cancer Immunotherapies market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Immunotherapies.
Chapter 14 and 15, to describe Cancer Immunotherapies sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Immunotherapies
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cancer Immunotherapies Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Monoclonal Antibodies (MABs)
    • 1.3.3 Cancer Vaccines
    • 1.3.4 Immunomodulators
    • 1.3.5 Adoptive Cell transfer
    • 1.3.6 Checkpoint Inhibitors
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cancer Immunotherapies Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Breast Cancer
    • 1.4.3 Leukemia
    • 1.4.4 Lymphoma
    • 1.4.5 Melanoma
    • 1.4.6 Colorectal Cancer
    • 1.4.7 Non-Small Cell Lung Cancer
  • 1.5 Global Cancer Immunotherapies Market Size & Forecast
    • 1.5.1 Global Cancer Immunotherapies Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cancer Immunotherapies Sales Quantity (2019-2030)
    • 1.5.3 Global Cancer Immunotherapies Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Amgen
    • 2.1.1 Amgen Details
    • 2.1.2 Amgen Major Business
    • 2.1.3 Amgen Cancer Immunotherapies Product and Services
    • 2.1.4 Amgen Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Amgen Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Cancer Immunotherapies Product and Services
    • 2.2.4 AstraZeneca Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Cancer Immunotherapies Product and Services
    • 2.3.4 Roche Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Roche Recent Developments/Updates
  • 2.4 Bristol-Myers Squibb
    • 2.4.1 Bristol-Myers Squibb Details
    • 2.4.2 Bristol-Myers Squibb Major Business
    • 2.4.3 Bristol-Myers Squibb Cancer Immunotherapies Product and Services
    • 2.4.4 Bristol-Myers Squibb Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Cancer Immunotherapies Product and Services
    • 2.5.4 Bayer Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bayer Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Cancer Immunotherapies Product and Services
    • 2.6.4 Merck Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 ARMO BioSciences (Eli Lilly)
    • 2.7.1 ARMO BioSciences (Eli Lilly) Details
    • 2.7.2 ARMO BioSciences (Eli Lilly) Major Business
    • 2.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Product and Services
    • 2.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 ARMO BioSciences (Eli Lilly) Recent Developments/Updates
  • 2.8 Novartis
    • 2.8.1 Novartis Details
    • 2.8.2 Novartis Major Business
    • 2.8.3 Novartis Cancer Immunotherapies Product and Services
    • 2.8.4 Novartis Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Novartis Recent Developments/Updates
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Cancer Immunotherapies Product and Services
    • 2.9.4 Pfizer Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments/Updates
  • 2.10 Johnson & Johnson
    • 2.10.1 Johnson & Johnson Details
    • 2.10.2 Johnson & Johnson Major Business
    • 2.10.3 Johnson & Johnson Cancer Immunotherapies Product and Services
    • 2.10.4 Johnson & Johnson Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Johnson & Johnson Recent Developments/Updates
  • 2.11 AbbVie
    • 2.11.1 AbbVie Details
    • 2.11.2 AbbVie Major Business
    • 2.11.3 AbbVie Cancer Immunotherapies Product and Services
    • 2.11.4 AbbVie Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 AbbVie Recent Developments/Updates
  • 2.12 Gilead Sciences
    • 2.12.1 Gilead Sciences Details
    • 2.12.2 Gilead Sciences Major Business
    • 2.12.3 Gilead Sciences Cancer Immunotherapies Product and Services
    • 2.12.4 Gilead Sciences Cancer Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Gilead Sciences Recent Developments/Updates

3 Competitive Environment: Cancer Immunotherapies by Manufacturer

  • 3.1 Global Cancer Immunotherapies Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cancer Immunotherapies Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cancer Immunotherapies Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cancer Immunotherapies by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cancer Immunotherapies Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Cancer Immunotherapies Manufacturer Market Share in 2023
  • 3.5 Cancer Immunotherapies Market: Overall Company Footprint Analysis
    • 3.5.1 Cancer Immunotherapies Market: Region Footprint
    • 3.5.2 Cancer Immunotherapies Market: Company Product Type Footprint
    • 3.5.3 Cancer Immunotherapies Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cancer Immunotherapies Market Size by Region
    • 4.1.1 Global Cancer Immunotherapies Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cancer Immunotherapies Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cancer Immunotherapies Average Price by Region (2019-2030)
  • 4.2 North America Cancer Immunotherapies Consumption Value (2019-2030)
  • 4.3 Europe Cancer Immunotherapies Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cancer Immunotherapies Consumption Value (2019-2030)
  • 4.5 South America Cancer Immunotherapies Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Cancer Immunotherapies Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 5.2 Global Cancer Immunotherapies Consumption Value by Type (2019-2030)
  • 5.3 Global Cancer Immunotherapies Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 6.2 Global Cancer Immunotherapies Consumption Value by Application (2019-2030)
  • 6.3 Global Cancer Immunotherapies Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 7.2 North America Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 7.3 North America Cancer Immunotherapies Market Size by Country
    • 7.3.1 North America Cancer Immunotherapies Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cancer Immunotherapies Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cancer Immunotherapies Market Size by Country
    • 8.3.1 Europe Cancer Immunotherapies Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cancer Immunotherapies Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cancer Immunotherapies Market Size by Region
    • 9.3.1 Asia-Pacific Cancer Immunotherapies Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cancer Immunotherapies Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 10.2 South America Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 10.3 South America Cancer Immunotherapies Market Size by Country
    • 10.3.1 South America Cancer Immunotherapies Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cancer Immunotherapies Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cancer Immunotherapies Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cancer Immunotherapies Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cancer Immunotherapies Market Size by Country
    • 11.3.1 Middle East & Africa Cancer Immunotherapies Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cancer Immunotherapies Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cancer Immunotherapies Market Drivers
  • 12.2 Cancer Immunotherapies Market Restraints
  • 12.3 Cancer Immunotherapies Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cancer Immunotherapies and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cancer Immunotherapies
  • 13.3 Cancer Immunotherapies Production Process
  • 13.4 Cancer Immunotherapies Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cancer Immunotherapies Typical Distributors
  • 14.3 Cancer Immunotherapies Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Immunotherapies. Industry analysis & Market Report on Cancer Immunotherapies is a syndicated market report, published as Global Cancer Immunotherapies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Immunotherapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo